Table 15.
No.a | Studies supporting the conclusion | Microbial organisms (isolated from calf faeces), antimicrobials (AMs) and/or resistance mechanisms investigated |
---|---|---|
1 | Dolejská et al. (2008) | Escherichia coli; 12 AMs |
Kyselková et al. (2015) | tet (tetracycline resistance) genes by PCR | |
Duse et al. (2015) | E. coli; 12 AMs | |
Brunton et al. (2014) | E. coli; cefquinome | |
Aust et al. (2013) | E. coli; 25 AMs | |
Langford et al. (2003) | Bacteria; penicillin | |
Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate | |
2 | Aust et al. (2013) | E. coli; 25 AMs |
3 | Aust et al. (2013) | Enterococcus faecalis; 25 AMs |
4 | Duse et al. (2015) | E. coli; penicillin and aminoglycosides |
5 | Gonggrijp et al. (2015) | E. coli; ESBL/AmpC‐encoding genes |
6 | Kyselková et al. (2015) | tet (tetracycline resistance) genes by PCR |
Randall et al. (2014) | E. coli; AMs and CTX‐M encoding genes | |
Brunton et al. (2014) | E. coli; cefquinome | |
Aust et al. (2013) | E. coli; 25 AMs | |
Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
Alali et al. (2004) | E. coli O157:H7; nalidixic acid resistant | |
7 | Brunton et al. (2014) | E. coli; cefquinome |
8 | Duse et al. (2015) | E. coli; 12 AMs |
Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate | |
9 | Duse et al., 2015; | E. coli; 12 AMs |
10 | Langford et al. (2003) | Bacteria; penicillin resistance |
Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate |
PCR: polymerase chain reaction.
The numbers relate to the numbered summary remarks.